KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 72 filers reported holding KRONOS BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,795,759 | -25.3% | 1,381,352 | -1.1% | 0.00% | – |
| Q2 2023 | $2,403,434 | -47.6% | 1,397,345 | -55.6% | 0.00% | – |
| Q1 2023 | $4,590,404 | -11.6% | 3,144,113 | -2.0% | 0.00% | – |
| Q4 2022 | $5,195,153 | -55.3% | 3,206,885 | -7.5% | 0.00% | – |
| Q3 2022 | $11,614,000 | -9.0% | 3,466,420 | -1.1% | 0.00% | – |
| Q2 2022 | $12,764,000 | -48.1% | 3,506,605 | +3.1% | 0.00% | -100.0% |
| Q1 2022 | $24,593,000 | -46.3% | 3,401,730 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $45,794,000 | -25.5% | 3,369,676 | +14.9% | 0.00% | -50.0% |
| Q3 2021 | $61,465,000 | -9.1% | 2,932,521 | +3.9% | 0.00% | 0.0% |
| Q2 2021 | $67,594,000 | +41.2% | 2,822,245 | +72.6% | 0.00% | +100.0% |
| Q1 2021 | $47,871,000 | +5.0% | 1,635,564 | +7.1% | 0.00% | 0.0% |
| Q4 2020 | $45,603,000 | – | 1,526,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $9,264,000 | 8.31% |
| Omega Fund Management, LLC | 3,818,283 | $12,791,000 | 4.68% |
| Privium Fund Management (UK) Ltd | 645,331 | $2,162,000 | 2.76% |
| Wildcat Capital Management, LLC | 1,438,232 | $4,818,000 | 1.85% |
| Nextech Invest Ltd. | 1,451,537 | $4,863,000 | 1.57% |
| Alphabet Inc. | 1,438,232 | $4,818,000 | 0.25% |
| Artal Group S.A. | 1,542,954 | $5,169,000 | 0.22% |
| Perceptive Advisors | 2,156,151 | $7,223,000 | 0.21% |
| Oasis Management Co Ltd. | 196,078 | $657,000 | 0.11% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $1,767,000 | 0.10% |